What are the supportive over-the-counter (OTC) treatments for Respiratory Syncytial Virus (RSV) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Treatment for Respiratory Syncytial Virus (RSV) is primarily supportive, focusing on managing symptoms while the body fights the infection. Over-the-counter options include acetaminophen (Tylenol) or ibuprofen (Advil, Motrin) for fever and discomfort, dosed according to age and weight as directed on packaging 1. Nasal saline drops followed by gentle suction with a bulb syringe can help clear congestion, especially before feeding and sleep. Adequate hydration is crucial, so encourage fluids to prevent dehydration and thin mucus secretions. A cool-mist humidifier in the sleeping area can ease breathing by moistening air passages. For cough, honey may help children over 1 year (never give honey to infants under 12 months due to botulism risk) 1.

Supportive Care Measures

  • Use of analgesics or antipyretic drugs, such as acetaminophen or ibuprofen, for pain or fever management
  • Nasal saline for palliative and cleansing purposes
  • Oral decongestants for symptomatic relief, with consideration of medical contraindications
  • Topical decongestants for short-term use, not exceeding 3 to 5 days
  • Antihistamines for symptomatic relief of excessive secretions and sneezing, although evidence is limited
  • Guaifenesin (an expectorant) and dextromethorphan (a cough suppressant) may be used based on patient and provider preference, despite lacking clinical efficacy evidence

Prevention and Vaccination

Recent studies have focused on the development and recommendation of RSV vaccines for high-risk populations, including older adults and young children 1. However, these are not directly related to over-the-counter treatments for managing symptoms of RSV infection.

Key Considerations

Most RSV infections resolve within 1-2 weeks, but it is crucial to seek medical attention if breathing becomes labored, the person appears dehydrated, or symptoms worsen significantly 1. The use of monoclonal antibodies like palivizumab and nirsevimab has been recommended for prevention of RSV disease in high-risk infants and young children 1, but these are not over-the-counter treatments.

Conclusion is not allowed, so the answer ends here.

From the Research

Supportive Over-the-Counter (OTC) Treatments for RSV Infection

  • The primary treatment for Respiratory Syncytial Virus (RSV) infection is supportive care, focusing on maintaining hydration and oxygenation 2.
  • There are no specific over-the-counter (OTC) medications available to treat RSV infection, and treatment is mainly focused on alleviating symptoms 3, 2.
  • For high-risk infants, palivizumab prophylaxis may be used to decrease hospitalization and length of stay 3, 4, 5.
  • Immunocompromised patients may be treated with ribavirin and palivizumab 3.
  • Bronchodilators may be used for children with wheezing, but should not be continued unless there is a prompt favorable response 2.

Prevention of RSV Infection

  • Frequent hand washing and contact isolation may prevent the spread of RSV infections 2.
  • Palivizumab prophylaxis is available for high-risk infants and children, including those born before 35 weeks of gestation and those with chronic lung or cardiac problems 4, 2, 5.
  • Novel antibodies and vaccines are being developed for the prevention and treatment of RSV infection, but are not yet widely available 4, 6, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Respiratory syncytial virus infection in children.

American family physician, 2011

Research

Respiratory syncytial virus: diagnosis, treatment and prevention.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2009

Research

Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Infection.

The Pediatric infectious disease journal, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.